Erythromycin
( DrugBank: Erythromycin / KEGG DRUG: Erythromycin, Erythromycin estolate, Erythromycin ethylsuccinate, Erythromycin lactobionate, Erythromycin stearate, Erythromycin gluceptate, Erythromycin thiocyanate )
6 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 164 | 眼皮膚白皮症 | 1 |
| 228 | 閉塞性細気管支炎 | 1 |
| 291 | ヒルシュスプルング病（全結腸型又は小腸型） | 1 |
2. 筋萎縮性側索硬化症
臨床試験数 : 867 / 薬物数 : 820 - (DrugBank : 185) / 標的遺伝子数 : 189 - 標的パスウェイ数 : 237
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
6. パーキンソン病
臨床試験数 : 2,817 / 薬物数 : 2,606 - (DrugBank : 348) / 標的遺伝子数 : 185 - 標的パスウェイ数 : 205
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
36. 表皮水疱症
臨床試験数 : 197 / 薬物数 : 223 - (DrugBank : 46) / 標的遺伝子数 : 53 - 標的パスウェイ数 : 136
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
164. 眼皮膚白皮症
臨床試験数 : 17 / 薬物数 : 57 - (DrugBank : 32) / 標的遺伝子数 : 32 - 標的パスウェイ数 : 139
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
228. 閉塞性細気管支炎
臨床試験数 : 112 / 薬物数 : 139 - (DrugBank : 31) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 161
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
291. ヒルシュスプルング病（全結腸型又は小腸型）
臨床試験数 : 18 / 薬物数 : 35 - (DrugBank : 11) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|